ClinicalTrials.Veeva

Menu

Comparison Between Two Techniques in Treatment of Female Stress Urinary Incontinence

K

Kafrelsheikh University

Status and phase

Completed
Phase 3

Conditions

Female Stress Urinary Incontinence

Treatments

Biological: Platelet rich fibrin
Biological: Platelet Rich Plasma

Study type

Interventional

Funder types

Other

Identifiers

NCT07366762
KFSIRB200-320

Details and patient eligibility

About

compare the therapeutic effect of periurethral injection of autologous platelet-rich plasma (PRP) and injectable platelet rich fibrin (i-PRF) in treatment of female stress urinary incontinence and comparing the need for re-injection in the two groups.

Enrollment

40 patients

Sex

Female

Ages

30 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female patients with primary symptoms of SUI confirmed by patient's medical history and clinical examination, including a focused incontinence evaluation

    • Age range of 30-75 years
    • Females unfit for surgery
    • Females with SUI recurrence after previous surgical procedure by suburethal sling
    • Females refusing surgical interventions

Exclusion criteria

  • Residual urine volume exceeding 100 cc after excretion
  • Evidence of detrusor over-activity on the urodynamic test
  • Active urinary tract or vaginal infection
  • Malignancies of the genitourinary system
  • Patients with genitourinary fistula or urethral diverticulum

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

group one who had received PRP injections
Active Comparator group
Treatment:
Biological: Platelet Rich Plasma
group two who had received i-PRF injections
Active Comparator group
Treatment:
Biological: Platelet rich fibrin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems